Sapropterin dihydrochloride
Showing 1 - 25 of 101
Head and Neck Squamous Cell Carcinoma Trial (Sapropterin diHCl tablets)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Sapropterin dihydrochloride tablets
- (no location specified)
Mar 17, 2022
Phenylketonuria Trial in Fargo (sapropterin diHCl, Moxifloxacin, Moxifloxacin )
Completed
- Phenylketonuria
- sapropterin dihydrochloride
- +2 more
-
Fargo, North DakotaPRACS Institute, Ltd.
Jul 19, 2021
Schizo Affective Disorder, Schizophrenia Trial in Worcester (L-arginine, Sapropterin DiHCl)
Withdrawn
- Schizo Affective Disorder
- Schizophrenia
- L-arginine
- Sapropterin Dihydrochloride
-
Worcester, MassachusettsUMass Medical School
Jan 4, 2022
Endothelial Dysfunction Trial in Hackensack (Sapropterin DiHCl, Sapropterin DiHCl and Vitamin C)
Completed
- Endothelial Dysfunction
- Sapropterin Dihydrochloride
- Sapropterin Dihydrochloride and Vitamin C
-
Hackensack, New Jersey(unnamed)
Apr 22, 2021
Intermittent Claudication Trial in Argentina, United States (Placebo, Sapropterin DiHCl)
Completed
- Intermittent Claudication
- Placebo
- Sapropterin Dihydrochloride
-
Scottsdale, Arizona
- +19 more
Dec 14, 2020
COPD (COPD) Trial in Augusta (Tetrahydrobiopterin (BH4), Antioxidant Cocktail)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- Tetrahydrobiopterin (BH4)
- Antioxidant Cocktail
-
Augusta, GeorgiaGeorgia Prevention Institute
Feb 5, 2021
Sickle Cell Disease Trial in United States (Sapropterin DiHCl)
Completed
- Sickle Cell Disease
- Sapropterin Dihydrochloride
-
Washington, District of Columbia
- +11 more
Feb 3, 2021
Peripheral Artery Disease, Peripheral Arterial Disease Trial (Sapropterin DiHCl (BH4, tetrahydrobiopterin), Placebo)
Withdrawn
- Peripheral Artery Disease
- Peripheral Arterial Disease
- Sapropterin Dihydrochloride (BH4, tetrahydrobiopterin)
- Placebo
- (no location specified)
Nov 24, 2020
Phenylketonuria Trial in Canada, United States (sapropterin diHCl)
Completed
- Phenylketonuria
- sapropterin dihydrochloride
-
La Jolla, California
- +18 more
Dec 1, 2020
Gastroparesis Trial in Stanford (sapropterin diHCl)
Completed
- Gastroparesis
- sapropterin dihydrochloride
-
Stanford, CaliforniaStanford University School of Medicine
Sep 6, 2019
PKUDOS: Phenylketonuria Demographic, Outcomes, and Safety
Completed
- Phenylketonuria
- Hyperphenylalaninaemia
-
Los Angeles, California
- +44 more
Oct 11, 2022
Phenylketonuria Trial in Miami (Kuvan, Diet)
Completed
- Phenylketonuria
- Kuvan
- Diet
-
Miami, FloridaDepartment of Biochemistry & Molecular Biology
Nov 19, 2019
Heart Failure, Cardiovascular Disease Trial in Providence (Kuvan)
Completed
- Heart Failure
- Cardiovascular Disease
-
Providence, Rhode IslandProvidence VAMC
Jan 28, 2019
Simple Breath Test to Examine Phenylalanine Metabolism
Completed
- Phenylketonuria (PKU)
-
Vancouver, British Columbia, CanadaChild & Family Research Institute
Sep 22, 2020
Executive Function, Neurotransmitter Function and Genomic
Completed
- Phenylketonuria
- +2 more
- sapropterin dihydrochloride
-
New Orleans, LouisianaTulane University Health Science Center
Sep 13, 2018
Phenylketonuria Trial in Cleveland (saproterin diHCl, Diet treatment)
Completed
- Phenylketonuria
- saproterin dihydrochloride
- Diet treatment
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center
Apr 26, 2022
The Brain and Neuropsychological Functioning in Sapropterin
Completed
- Phenylketonuria
-
Boston, MassachusettsBoston Children's Hospital
Feb 1, 2018
Idiopathic Pulmonary Fibrosis Trial in Beijing (Jaktinib DiHCl Monohydrate 50mg BID and Mimic tablets of jakitinib HCl 75mg BID
Recruiting
- Idiopathic Pulmonary Fibrosis
- Jaktinib Dihydrochloride Monohydrate 50mg BID and Mimic tablets of jakitinib hydrochloride 75mg BID and Acetylcysteine Effervescent Tablets
- +2 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Nov 29, 2021
Immune System Diseases Trial in Lugo (10 HEP/mL Betula verrucosa allergen extract, 25 HEP/mL Betula verrucosa allergen extract,
Completed
- Immune System Diseases
- 10 HEP/mL Betula verrucosa allergen extract
- +3 more
-
Lugo, Galicia, SpainHospital Lucus Augusti
May 4, 2022
Pancreatic Cancer, Surgery, Metastasis Trial (Histamine DiHCl (HDC), Interleukin-2 (IL-2))
Not yet recruiting
- Pancreatic Cancer
- +3 more
- Histamine Dihydrochloride (HDC)
- Interleukin-2 (IL-2)
- (no location specified)
Mar 31, 2023
Anaplastic Thyroid Cancer, Recurrent Thyroid Cancer Trial in United States (efatutazone, paclitaxel)
Active, not recruiting
- Anaplastic Thyroid Cancer
- Recurrent Thyroid Cancer
-
Anchorage, Alaska
- +252 more
Aug 16, 2021
Liposarcoma Trial in United States (efatutazone)
Active, not recruiting
- Liposarcoma
-
Little Rock, Arkansas
- +126 more
Aug 16, 2021
Phenylketonuria Trial in Pittsburgh (radiation, procedure, drug, other, behavioral, diagnostic test)
Recruiting
- Phenylketonuria
- Preparative Radiation Therapy
- +6 more
-
Pittsburgh, Pennsylvania
- +1 more
Jan 9, 2023
Cystic Fibrosis Trial in Augusta (BH4 5mg, BH4 20mg, Antioxidant Cocktail)
Completed
- Cystic Fibrosis
- BH4 5mg
- +2 more
-
Augusta, GeorgiaGeorgia Prevention Institute/ Laboratory of Integrative and Exer
Jun 18, 2019